Publication | Open Access
Mipomersen (kynamro): a novel antisense oligonucleotide inhibitor for the management of homozygous familial hypercholesterolemia.
81
Citations
1
References
2014
Year
Molecular PharmacologyMetabolic SyndromeLipid DisorderHomozygous Familial HypercholesterolemiaCardiovascular DiseaseInherited Metabolic DiseasePharmacologyHyperlipidemiaPharmacotherapyAntisense TherapyMedicineAtherosclerosisDyslipidemiaDrug Discovery
Mipomersen (Kynamro) for homozygous familial hypercholesterolemia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1